CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute (5 P50 CA070907, CA016672, 1R01CA190628, 1R01CA234183-01A1, 1R01CA240257, 1R01CA247975, 1R50CA265307)
  • Cancer Prevention and Research Institute of Texas (RP120348, RP170002)
  • Emerson Collective
  • National Institutes of Health

This publication has 73 references indexed in Scilit: